Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lillian Sun

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal for Immunotherapy of Cancer|June 22, 2018
Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapiesJay Friedman, Megan Morisada, Lillian Sun, et al.
Scientific Reports|March 19, 2021
Death agonist antibody against TRAILR2/DR5/TNFRSF10B enhances birinapant anti-tumor activity in HPV-positive head and neck squamous cell carcinomasYi An, Jun Jeon, Lillian Sun, et al.
Oncoimmunology|October 6, 2018
WEE1 kinase inhibition reverses G2/M cell cycle checkpoint activation to sensitize cancer cells to immunotherapyLillian Sun, Ellen Moore, Rose Berman, et al.
Oncoimmunology|February 6, 2018
PD-1 blockade reverses adaptive immune resistance induced by high-dose hypofractionated but not low-dose daily fractionated radiationMegan Morisada, Paul E Clavijo, Ellen Moore, et al.
Oncoimmunology|June 15, 2018
Nanocomplex-based <i>TP53</i> gene therapy promotes anti-tumor immunity through TP53- and STING-dependent mechanismsEllen C Moore, Lillian Sun, Paul E Clavijo, et al.
Archives of Gynecology and Obstetrics|July 1, 2026
Diagnostic and treatment delay in women with cancer in pregnancy: a case-based studyLillian Sun Liang, Iben Katinka Greiber, Mona Aarenstrup Karlsen, et al.
JAMA Dermatology|February 28, 2019
Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality TherapyLillian Sun, Re-I Chin, Brian Gastman, et al.
JCI Insight|April 5, 2019
Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapyLillian Sun, Paul E Clavijo, Yvette Robbins, et al.
Immunity|November 13, 2012
Inactivation of the enzyme GSK3α by the kinase IKKi promotes AKT-mTOR signaling pathway that mediates interleukin-1-induced Th17 cell maintenanceMuhammet F Gulen, Katarzyna Bulek, Hui Xiao, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal for Immunotherapy of Cancer|June 22, 2018
Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapiesJay Friedman, Megan Morisada, Lillian Sun, et al.
Scientific Reports|March 19, 2021
Death agonist antibody against TRAILR2/DR5/TNFRSF10B enhances birinapant anti-tumor activity in HPV-positive head and neck squamous cell carcinomasYi An, Jun Jeon, Lillian Sun, et al.
Oncoimmunology|October 6, 2018
WEE1 kinase inhibition reverses G2/M cell cycle checkpoint activation to sensitize cancer cells to immunotherapyLillian Sun, Ellen Moore, Rose Berman, et al.
Oncoimmunology|February 6, 2018
PD-1 blockade reverses adaptive immune resistance induced by high-dose hypofractionated but not low-dose daily fractionated radiationMegan Morisada, Paul E Clavijo, Ellen Moore, et al.
Oncoimmunology|June 15, 2018
Nanocomplex-based <i>TP53</i> gene therapy promotes anti-tumor immunity through TP53- and STING-dependent mechanismsEllen C Moore, Lillian Sun, Paul E Clavijo, et al.
Archives of Gynecology and Obstetrics|July 1, 2026
Diagnostic and treatment delay in women with cancer in pregnancy: a case-based studyLillian Sun Liang, Iben Katinka Greiber, Mona Aarenstrup Karlsen, et al.
JAMA Dermatology|February 28, 2019
Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality TherapyLillian Sun, Re-I Chin, Brian Gastman, et al.
JCI Insight|April 5, 2019
Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapyLillian Sun, Paul E Clavijo, Yvette Robbins, et al.
Immunity|November 13, 2012
Inactivation of the enzyme GSK3α by the kinase IKKi promotes AKT-mTOR signaling pathway that mediates interleukin-1-induced Th17 cell maintenanceMuhammet F Gulen, Katarzyna Bulek, Hui Xiao, et al.
Pageof 2